Primary Outcome from a cluster-randomized trial of three formats for delivering Community Reinforcement and Family Training (CRAFT) to the significant others of problem drinkers

BMC Public Health

Morten Hesse¹  Kjeld Andersen²  Gallus Bischof³  Anette Søgaard Nielsen⁴  Rikke Hellum⁴  Randi Bilberg⁴ 

[1] Centre for Alcohol and Drug Research, Department of Psychological and Behavioral Sciences, Aarhus University;Psychiatric Department, Region of Southern Denmark;The Department of Psychiatry and Psychotherapy, University of Luebeck;The Unit of Clinical Alcohol Research (UCAR), Institute of Clinical Research, University of Southern Denmark;

关键词: Community Reinforcement and Family Training;    CRAFT;    Concerned significant others;    Alcohol treatment;    Treatment engagement;    Alcohol use disorder;   

DOI  :  10.1186/s12889-022-13293-8

来源: DOAJ

【 摘 要 】

Abstract Background Community Reinforcement and Family Training (CRAFT) is an intervention designed to help the concerned significant others (CSOs) of people with alcohol problems who are reluctant to seek treatment. It aims to improve the well-being of CSOs and teach them how to change their behavior in order to positively influence the “identified patient” (IP) to seek treatment. Methods The aim of the present pragmatic cluster-randomized trial was to compare the effectiveness of three formats for delivering CRAFT in real life settings: group sessions, individual sessions, and written material only (control group). Eighteen public treatment centers for alcohol use disorders were randomly assigned to deliver CRAFT in one of the three formats as part of their daily clinical routine. CSOs were recruited via pamphlets, general practitioners, and advertisements on social media. Trained clinicians delivered CRAFT in individual and group format, and self-administered CRAFT was limited to handing out a self-help book. The primary outcome was treatment engagement of the IP after three months. Results A total of 249 CSOs were found to be eligible and randomly assigned to receive CRAFT delivered in group, individual, or self-administered format. The three-month follow-up rate was 60%. At three months follow-up, 29% (n = 32) of the CSOs who received group/individual CRAFT reported that their IP had engaged in treatment. The corresponding rate for the CSOs who received self-administered CRAFT was lower (15%; n = 5) but did not differ significantly from the other group of CSOs (Odds ratio (OR) = 2.27 (95% CI: 0.80, 6.41)). Conclusion We hypothesized that CSOs receiving CRAFT in a group format would improve the most, but although our findings pointed in this direction, the differences were not statistically significant. Trial registration Clinical trials.gov ID: NCT03281057 . Registration date:13/09/2017.

【 授权许可】

Unknown